A huge development overnight has the stock market rallying early Friday morning. Reports claim that a drug named remdesivir has helped treat those suffering severe symptoms of the coronavirus COVID-19. The report from STAT news says the drug was the first to show positive healing effects in lab tests and …
Read More »CARES Act allows the unemployed to take on a side gig and still collect benefits — here’s why you should tread carefully
If you’re one of the 6.6 million Americans who filed for unemployment benefits last week there’s a good chance you’re anxiously waiting for a check to arrive in the mail. In the meantime, you might consider taking on gig work. What you may have given less consideration to is how …
Read More »The Moneyist: ‘These dogs have been kissed and cuddled by their owners.’ How is our pet salon still open when human salons are closed?
Dear Moneyist, I am a pet stylist. I feel most people would agree that my job definitely falls into the nonessential category and it is, in fact, on the list of nonessential businesses ordered closed by my state and by the town in which I work. The problem is, I …
Read More »New York City welcomes more hospital beds, but still needs many more
A handful of white tents popped up in Central Park’s East Meadow on Sunday. The structures are Mount Sinai Hospital’s new 68-bed field hospital and are just one creative way that New York City is hoping to create 40,000 more hospital beds. Mayor Bill de Blasio estimates that the city …
Read More »In One Chart: Warren Buffett’s ‘yardstick’ for stock-market values still points to ‘very elevated’ downside risk
The stock market broke new ground last week in terms of the breakneck speed of its selloff, with the S&P 500 SPX, -2.34% dropping 10% from its record high in a mere six days, faster than any other time in history. Must be some hot bargains out there, with stocks …
Read More »The Ratings Game: Tesla’s stock bounces, but Morgan Stanley says it’s still a sell
Shares of Tesla Inc. shot higher Monday, putting them on track to snap a sharp 5-day selloff, but Morgan Stanley analyst Adam Jonas suggested it was still too early for investors to jump in. Jonas reiterated the underweight rating he’s had on the stock since he downgraded it on Jan. …
Read More »